Pew Scholar Elected Into Institute of Medicine

During its 44th annual meeting Oct. 20, the Institute of Medicine announced 70 new members, including 2005 Pew biomedical scholar Gonçalo R. Abecasis. Considered to be one of the highest honors in the fields of health and medicine, election to the IOM recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

As the Felix E. Moore Collegiate Professor of Biostatistics and chair of the biostatistics department at the University of Michigan in Ann Arbor, Abecasis studies the genes involved in human diseases. Specifically, he is developing analytical methods and statistical tools that will facilitate the mapping of complex genetic traits. His applied projects focus on the genetics of aging, inherited eye diseases, inflammatory diseases, and psychiatric disorders.

"These leaders' tremendous achievements have contributed significantly to advancing health and medicine,” said IOM President Victor J. Dzau of the new members. “The expertise and knowledge they bring to the IOM will encourage and enhance its success."

Learn more about Pew’s biomedical programs.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.